Home
>
National Drug Code (NDC)
>
Cytarabine
Cytarabine - 55390-132-10 - (Cytarabine)
Drug Information of Cytarabine
| Product NDC: | 55390-132 |
| Proprietary Name: | Cytarabine |
| Non Proprietary Name: | Cytarabine |
| Active Ingredient(s): | 500 mg/10mL & nbsp; Cytarabine |
| Administration Route(s): | INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Cytarabine
| Product NDC: | 55390-132 |
| Labeler Name: | Bedford Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA071472 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19960501 |
Package Information of Cytarabine
| Package NDC: | 55390-132-10 |
| Package Description: | 10 VIAL in 1 BOX (55390-132-10) > 10 mL in 1 VIAL |
NDC Information of Cytarabine
| NDC Code | 55390-132-10 |
| Proprietary Name | Cytarabine |
| Package Description | 10 VIAL in 1 BOX (55390-132-10) > 10 mL in 1 VIAL |
| Product NDC | 55390-132 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cytarabine |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 19960501 |
| Marketing Category Name | ANDA |
| Labeler Name | Bedford Laboratories |
| Substance Name | CYTARABINE |
| Strength Number | 500 |
| Strength Unit | mg/10mL |
| Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
